These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 18853747)

  • 41. The winding road to the discovery of the SR/CR mice.
    Cui Z
    Cancer Immun; 2003 Oct; 3():14. PubMed ID: 14561079
    [No Abstract]   [Full Text] [Related]  

  • 42. Spontaneous regression of advanced cancer: identification of a unique genetically determined, age-dependent trait in mice.
    Cui Z; Willingham MC; Hicks AM; Alexander-Miller MA; Howard TD; Hawkins GA; Miller MS; Weir HM; Du W; DeLong CJ
    Proc Natl Acad Sci U S A; 2003 May; 100(11):6682-7. PubMed ID: 12724523
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of aging on cellular immunity against cancer in SR/CR mice.
    Cui Z; Willingham MC
    Cancer Immunol Immunother; 2004 Jun; 53(6):473-8. PubMed ID: 14730401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Untimely ends and new beginnings in mouse cloning.
    Perry AC; Wakayama T
    Nat Genet; 2002 Mar; 30(3):243-4. PubMed ID: 11919554
    [No Abstract]   [Full Text] [Related]  

  • 45. Litter seriation phenomena in fibrosarcoma susceptibility; a contribution to the subject of cancer susceptibility in relation to age.
    STRONG LC
    J Gerontol; 1951 Oct; 6(4):340-57. PubMed ID: 14888869
    [No Abstract]   [Full Text] [Related]  

  • 46. [Multiple tumors in mice of the low-cancer line C57BL].
    PARNES VA; LEVINA DM; ROMANOVA-TSKHOVREBOVA OD
    Patol Fiziol Eksp Ter; 1961; 5():26-31. PubMed ID: 13732930
    [No Abstract]   [Full Text] [Related]  

  • 47. [Time of the sexual maturation of various strains of mouse, with special reference to the NLC strain].
    RUDALI G; JULIARD L; YOURKOVSKI N; FAUTREL M
    J Physiol (Paris); 1957; 49(3):657-66. PubMed ID: 13476401
    [No Abstract]   [Full Text] [Related]  

  • 48. Novel innate cancer killing activity in humans.
    Blanks MJ; Stehle JR; Du W; Adams JM; Willingham MC; Allen GO; Hu JJ; Lovato J; Molnar I; Cui Z
    Cancer Cell Int; 2011 Aug; 11():26. PubMed ID: 21813015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Various characteristics of mice belonging to a new cancer strain: the Curie Foundation NLC strain].
    RUDALI G; YOURKOVSKI N; JULIARD L; FAUTREL M
    Bull Assoc Fr Etud Cancer; 1956; 43(3):364-83. PubMed ID: 13404364
    [No Abstract]   [Full Text] [Related]  

  • 50. The development of an isogenic subline of mice (C57BL/6-H-2d) resistant to transplantable neoplasms indigenous to strain C57BL.
    BORGES PR; KVEDAR BJ; FOERSTER GE
    J Natl Cancer Inst; 1954 Oct; 15(2):341-6. PubMed ID: 13233889
    [No Abstract]   [Full Text] [Related]  

  • 51. [Oncological characteristics of genetic strain CC-57 brown mice].
    MEDVEDEV NN
    Biull Eksp Biol Med; 1958 May; 45(5):104-6. PubMed ID: 13560528
    [No Abstract]   [Full Text] [Related]  

  • 52. Crystal substructure and physical properties of the superconducting phase Bi4(Sr,Cr)6Cu4O16+x.
    Tarascon JM; Le Page Y ; Barboux P; Bagley BG; Greene LH; McKinnon WR; Hull GW; Giroud M; Hwang DM
    Phys Rev B Condens Matter; 1988 Jun; 37(16):9382-9389. PubMed ID: 9944325
    [No Abstract]   [Full Text] [Related]  

  • 53. Corrigendum to Coagulation phenotype of wild-type mice on different genetic backgrounds.
    Lab Anim; 2019 Feb; 53(1):NP1-NP2. PubMed ID: 30561240
    [No Abstract]   [Full Text] [Related]  

  • 54. SR source to science.
    Hasnain SS; Helliwell JR; Kamitsubo H
    J Synchrotron Radiat; 2000 May; 7(Pt 3):115. PubMed ID: 16609183
    [No Abstract]   [Full Text] [Related]  

  • 55. Immune cells from SR/CR mice induce the regression of established tumors in BALB/c and C57BL/6 mice.
    Koch J; Hau J; Pravsgaard Christensen J; Elvang Jensen H; Bagge Hansen M; Rieneck K
    PLoS One; 2013; 8(3):e59995. PubMed ID: 23555858
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The spectrum of resistance in SR/CR mice: the critical role of chemoattraction in the cancer/leukocyte interaction.
    Riedlinger G; Adams J; Stehle JR; Blanks MJ; Sanders AM; Hicks AM; Willingham MC; Cui Z
    BMC Cancer; 2010 May; 10():179. PubMed ID: 20438640
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of sex, MHC, and age of recipients on the therapeutic effect of transferred leukocytes from cancer-resistant SR/CR mice.
    Stehle JR; Blanks MJ; Riedlinger G; Kim-Shapiro JW; Sanders AM; Adams JM; Willingham MC; Cui Z
    BMC Cancer; 2009 Sep; 9():328. PubMed ID: 19754973
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frequency of the cancer-resistant phenotype in SR/CR mice and the effect of litter seriation.
    Koch J; Boschian A; Hau J; Rieneck K
    In Vivo; 2008; 22(5):565-9. PubMed ID: 18853747
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The cellular cancer resistance of the SR/CR mouse.
    Koch J; Hau J; Jensen HE; Nielsen CH; Rieneck K
    APMIS; 2012 Dec; 120(12):974-87. PubMed ID: 23030360
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer resistance of SR/CR mice in the genetic knockout backgrounds of leukocyte effector mechanisms: determinations for functional requirements.
    Sanders AM; Stehle JR; Blanks MJ; Riedlinger G; Kim-Shapiro JW; Monjazeb AM; Adams JM; Willingham MC; Cui Z
    BMC Cancer; 2010 Mar; 10():121. PubMed ID: 20356394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.